Rediscovering area CA2: Unique properties and functions

Nature Reviews Neuroscience

Volumn 17, Issue 2, 2016, Pages 89-102

  Dudek, Serena M ^a   Alexander, Georgia M ^a   Farris, Shannon ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAERGIC SYSTEM; GENE EXPRESSION; HIPPOCAMPAL CA2 REGION; HUMAN; INHIBITION KINETICS; INTERNEURON; LONG TERM POTENTIATION; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOCIAL BEHAVIOR; SPATIAL ANALYSIS; STRATUM RADIATUM; SYNAPSE; ANIMAL; CYTOLOGY; LEARNING; NERVE CELL; NERVE CELL NETWORK; NERVE CELL PLASTICITY; PHYSIOLOGY;

ANIMALS; CA2 REGION, HIPPOCAMPAL; HUMANS; LEARNING; NERVE NET; NEURONAL PLASTICITY; NEURONS; SOCIAL BEHAVIOR;

EID: 84955607077     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn.2015.22     Document Type: Review

References (176)

1. van Strien N. M, Cappaert N. L. M, & Witter M. P. The anatomy of memory: an interactive overview of the parahippocampal-hippocampal network. Nat. Rev. Neurosci.10, 272-282 (2009).
2. Buzsaki G, & Moser E. I. Memory, navigation and theta rhythm in the hippocampal-entorhinal system. Nat. Neurosci. 16, 130-138 (2013).
3. Geva-Sagiv M, Las L, Yovel Y, & Ulanovsky N. Spatial cognition in bats and rats: from sensory acquisition to multiscale maps and navigation. Nat. Rev. Neurosci. 16, 94-108 (2015).
4. Goosens K. A. Hippocampal regulation of aversive memories. Curr. Opin. Neurobiol. 21, 460-466 (2011).
5. Felix-Ortiz A. C, & Tye K. M. Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior. J. Neurosci. 34, 586-595 (2014).
6. Lorente de Nó R. Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system. J. Psychol. Neurol. 46, 113-177 (1934).
7. Lein E. S, Zhao X, & Gage F. H. Defining a molecular atlas of the hippocampus using DNA microarrays and high-Throughput in situ hybridization. J. Neurosci. 24, 3879-3889 (2004).
8. Lein E. S, Callaway E. M, Albright T. D, & Gage F. H. Redefining the boundaries of the hippocampal CA2 subfield in the mouse using gene expression and 3 dimensional reconstruction. J. Comp. Neurol. 485, 1-10 (2005).
9. Kohara K, et al. Cell type-specific genetic and optogenetic tools reveal hippocampal CA2 circuits. Nat. Neurosci. 17, 269-279 (2014).
10. Cui Z, Gerfen C. R, & Young W. S. Hypothalamic and other connections with dorsal CA2 area of the mouse hippocampus. J. Comp. Neurol. 521, 1844-1866 (2013).
11. Zhang L, & Hernández V. S. Synaptic innervation to rat hippocampus by vasopressin-immuno-positive fibres from the hypothalamic supraoptic and paraventricular nuclei. Neuroscience. 228, 139-162 (2013).
12. Yanagihara M, & Niimi K. Substance P like immunoreactive projection to the hippocampal formation from the posterior hypothalamus in the cat. Brain Res. Bull. 22, 689-694 (1989).
13. Nadler J. V, Perry B. W, & Cotman C. W. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature. 271, 676-677 (1978).
14. Sloviter R. S, & Damiano B. P. Sustained electrical stimulation of the perforant path duplicates kainate-induced electrophysiological effects and hippocampal damage in rats. Neurosci. Lett. 24, 279-284 (1981).
15. Zhao M, Choi Y. S, Obrietan K, & Dudek S. M. Synaptic plasticity (and the lack thereof) in hippocampal CA2 neurons. J. Neurosci. 27, 12025-12032 (2007).
16. McLardy T. Some cell and fibre peculiarities of uncal hippocampus. Prog. Brain Res. 3, 71-78 (1963).
17. Laurberg S, & Zimmer J. Aberrant hippocampal mossy fibers in cats. Brain Res. 188, 555-559 (1980).
18. Hirama J, Shoumura K, Ichinohe N, You S, & Yonekura H. Cornu ammonis of the cat: lack of a separate field of CA2. J. Hirnforsch. 38, 487-493 (1997).
19. San Antonio A, Liban K, Ikrar T, Tsyganovskiy E, & Xu X. Distinct physiological and developmental properties of hippocampal CA2 subfield revealed by using anti-Purkinje cell protein 4 (PCP4) immunostaining. J. Comp. Neurol. 522, 1333-1354 (2014).
20. Munoz D. G. The distribution of chromogranin A like immunoreactivity in the human hippocampus coincides with the pattern of resistance to epilepsy-induced neuronal damage. Ann. Neurol. 27, 266-275 (1990).
21. Gaarskjaer F. B. The organization and development of the hippocampal mossy fiber system. Brain Res. 396, 335-357 (1986).
22. Woodhams P. L, Celio M. R, Ulfig N, & Witter M. P. Morphological and functional correlates of borders in the entorhinal cortex and hippocampus. Hippocampus. 3, 303-311 (1993).
23. Ishizuka N, Weber J, & Amaral D. G. Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J. Comp. Neurol. 295, 580-623 (1990).
24. Emoto N, et al. Basic fibroblast growth factor (FGF) in the central nervous system: identification of specific loci of basic FGF expression in the rat brain. Growth Factors. 2, 21-29 (1989).
25. Phillips H. S, Hains J. M, Laramee G. R, Rosenthal A, & Winslow J. W. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science. 250, 290-294 (1990).
26. Zhao X, et al. Transcriptional profiling reveals strict boundaries between hippocampal subregions. J. Comp. Neurol. 441, 187-196 (2001).
27. Mercer A, Trigg H. L, & Thomson A. M. Characterization of neurons in the CA2 subfield of the adult rat hippocampus. J. Neurosci. 27, 7329-7338 (2007).
28. Lee S. E, et al. RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory. Proc. Natl Acad. Sci. USA. 107, 16994-16998 (2010).
29. Shinohara Y, et al. Hippocampal CA3 and CA2 have distinct bilateral innervation patterns to CA1 in rodents. Eur. J. Neurosci. 35, 702-710 (2012).
30. Alexander G. M, et al. Social and novel contexts modify hippocampal CA2 representations of space. Nat. Commun. 7, 10300 (2016).
31. Wyszynski M, et al. Differential regional expression and ultrastructural localization of a-Actinin 2, a putative NMDA receptor-Anchoring protein, in rat brain. J. Neurosci. 18, 1383-1392 (1998).
32. Tóth K, & Freund T. F. Calbindin D28k containing nonpyramidal cells in the rat hippocampus: their immunoreactivity for GABA and projection to the medial septum. Neuroscience. 49, 793-805 (1992).
33. Maglóczky Z, Acsády L, & Freund T. F. Principal cells are the postsynaptic targets of supramammillary afferents in the hippocampus of the rat. Hippocampus. 4, 322-334 (1994).
34. Haglund L, Swanson L. W, & Köhler C. The projection of the supramammillary nucleus to the hippocampal formation: an immunohistochemical and anterograde transport study with the lectin PHA L in the rat. J. Comp. Neurol. 229, 171-185 (1984).
35. Nitsch R, & Leranth C. Substance P containing hypothalamic afferents to the monkey hippocampus: an immunocytochemical, tracing, and coexistence study. Exp. Brain Res. 101, 231-240 (1994).
36. Gall C, & Selawski L. Supramammillary afferents to guinea pig hippocampus contain substance P like immunoreactivity. Neurosci. Lett. 51, 171-176 (1984).
37. Borhegyi Z, & Leranth C. Distinct substance P-And calretinin-containing projections from the supramammillary area to the hippocampus in rats; a species difference between rats and monkeys. Exp. Brain Res. 115, 369-374 (1997).
38. Tamamaki N, Abe K, & Nojyo Y. Three-dimensional analysis of the whole axonal arbors originating from single CA2 pyramidal neurons in the rat hippocampus with the aid of a computer graphic technique. Brain Res. 452, 255-272 (1988).
39. Lein E. S, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 445, 168-176 (2006).
40. Swanson L. W, Wyss J. M, & Cowan W. M. An autoradiographic study of the organization of intrahippocampal association pathways in the rat. J. Comp. Neurol. 181, 681-715 (1978).
41. Llorens-Martín M, Jurado-Arjona J, Avila J, & Hernández F. Novel connection between newborn granule neurons and the hippocampal CA2 field. Exp. Neurol. 263, 285-292 (2015).
42. Opendak M, & Gould E. Adult neurogenesis: a substrate for experience-dependent change. Trends Cogn. Sci. 19, 151-161 (2015).
43. Borhegyi Z, & Leranth C. Substance P innervation of the rat hippocampal formation. J. Comp. Neurol. 384, 41-58 (1997).
44. Dong H. W, Swanson L. W, Chen L, Fanselow M. S, & Toga A. W. Genomic-Anatomic evidence for distinct functional domains in hippocampal field CA1. Proc. Natl Acad. Sci. USA. 106, 11794-11799 (2009).
45. Slomianka L, Amrein I, Knuesel I, Sørensen J. C, & Wolfer D. P. Hippocampal pyramidal cells: the reemergence of cortical lamination. Brain Struct. Funct. 216, 301-317 (2011).
46. Lee S. H, et al. Parvalbumin-positive basket cells differentiate among hippocampal pyramidal cells. Neuron. 82, 1129-1144 (2014).
47. Mizuseki K, Diba K, Pastalkova E, & Buzsáki G. Hippocampal CA1 pyramidal cells form functionally distinct sublayers. Nat. Neurosci. 14, 1174-1181 (2011).
48. Valero M, et al. Determinants of different deep and superficial CA1 pyramidal cell dynamics during sharp-wave ripples. Nat. Neurosci. 18, 1281-1290 (2015).
49. Ropireddy D, Bachus S. E, & Ascoli G. A. Non-homogeneous stereological properties of the rat hippocampus from high-resolution 3D serial reconstruction of thin histological sections. Neuroscience. 205, 91-111 (2012).
50. Andersen P, Bliss T. V. P, & Skrede K. K. Lamellar organization of hippocampal excitatory pathways. Exp. Brain Res. 13, 222-238 (1971).
51. Sekino Y, Obata K, Tanifuji M, Mizuno M, & Murayama J. Delayed signal propagation via CA2 in rat hippocampal slices revealed by optical recording. J. Neurophysiol. 78, 1662-1668 (1997).
52. Rowland D. C, et al. Transgenically targeted rabies virus demonstrates a major monosynaptic projection from hippocampal area CA2 to medial entorhinal layer II neurons. J. Neurosci. 33, 14889-14898 (2013).
53. Hitti F. L, & Siegelbaum S. A. The hippocampal CA2 region is essential for social memory. Nature. 508, 88-92 (2014).
54. Ishizuka N, Cowan W. M, & Amaral D. G A quantitative analysis of the dendritic organization of pyramidal cells in the rat hippocampus. J. Comp. Neurol. 362, 17-45 (1995).
55. Bartesaghi R, & Ravasi L. Pyramidal neuron types in field CA2 of the guinea pig. Brain Res. Bull. 50, 263-273 (1999).
56. Piskorowski R. A, & Chevaleyre V. Synaptic integration by different dendritic compartments of hippocampal CA1 and CA2 pyramidal neurons. Cell. Mol. Life Sci. 69, 75-88 (2011).
57. Sun Q, Srinivas K. V, Sotayo A, & Siegelbaum S. A. Dendritic Na+ spikes enable cortical input to drive action potential output from hippocampal CA2 pyramidal neurons. eLife. 3, e04551 (2014).
58. Chevaleyre V, & Siegelbaum S. A. Strong CA2 pyramidal neuron synapses define a powerful disynaptic cortico-hippocampal loop. Neuron. 66, 560-572 (2010).
59. Piskorowski R. A, & Chevaleyre V. Delta-opioid receptors mediate unique plasticity onto parvalbumin-expressing interneurons in area CA2 of the hippocampus. J. Neurosci. 33, 14567-14578 (2013).
60. Botcher N. A, Falck J. E, Thomson A. M, & Mercer A. Distribution of interneurons in the CA2 region of the rat hippocampus. Front. Neuroanat. 8, 104 (2014).
61. Talley E. M, Solorzano G, Lei Q, Kim D, & Bayliss D. A. CNS distribution of members of the two pore-domain (KCNK) potassium channel family. J. Neurosci. 21, 7491-7505 (2001).
62. Mathie A, Al Moubarak E, & Veale E. L. Gating of two pore domain potassium channels. J. Physiol. (Lond.) 588, 3149-3156 (2010).
63. Chang P. Y, Taylor P. E, & Jackson M. B. Voltage imaging reveals the CA1 region at the CA2 border as a focus for epileptiform discharges and long-Term potentiation in hippocampal slices. J. Neurophysiol. 98, 1309-1322 (2007).
64. Caruana D. A, Alexander G. M, & Dudek S. M. New insights into the regulation of synaptic plasticity from an unexpected place: hippocampal area CA2. Learn. Mem. 19, 391-400 (2012).
65. Boulanger L. M, et al. Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci. 15, 1532-1544 (1995).
66. Pelkey K. A, et al. Tyrosine phosphatase STEP is a tonic brake on induction of long-Term potentiation. Neuron. 34, 127-138 (2002).
67. Nasrallah K, Piskorowski R. A, & Chevaleyre V. Inhibitory plasticity permits the recruitment of CA2 pyramidal neurons by CA3. eNeuro http://dx.doi.org/.10.1523/ENEURO.0049-15.2015 (2015).
68. Simons S. B, Escobedo Y, Yasuda R, & Dudek S. M. Regional differences in hippocampal calcium handling provide a cellular mechanism for limiting plasticity. Proc. Natl Acad. Sci. USA. 106, 14080-14084 (2009).
69. Sangameswaran L, Hempstead J, & Morgan J. I. Molecular cloning of a neuron-specific transcript and its regulation during normal and aberrant cerebellar development. Proc. Natl Acad. Sci. USA. 86, 5651-5655 (1989).
70. Fukaya M, Yamazaki M, Sakimura K, & Watanabe M. Spatial diversity in gene expression for VDCC?. subunit family in developing and adult mouse brains. Neurosci. Res. 53, 376-383 (2005).
71. Kato A. S, Siuda E. R, Nisenbaum E. S, & Bredt D. S. AMPA receptor subunit-specific regulation by a distinct family of type II TARPs. Neuron. 59, 986-996 (2008).
72. Soto D, et al. Selective regulation of long-form calcium-permeable AMPA receptors by an atypical TARP, ?-5. Nat. Neurosci. 12, 277-285 (2009).
73. Vellano C. P, Lee S. E, Dudek S. M, & Hepler J. R. RGS14 at the interface of hippocampal signaling and synaptic plasticity. Trends Pharmacol. Sci. 32, 666-674 (2011).
74. Lee H. J, Caldwell H. K, Macbeth A. H, Tolu S. G, & Young W. S A conditional knockout mouse line of the oxytocin receptor. Endocrinology. 149, 3256-3263 (2008).
75. Young W. S, Li J, Wersinger S. R, & Palkovits M. The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience. 143, 1031-1039 (2006).
76. Pagani J. H, et al. Role of the vasopressin 1b receptor in rodent aggressive behavior and synaptic plasticity in hippocampal area CA2. Mol. Psychiatry. 20, 490-499 (2015).
77. Ochiishi T, et al. High level of adenosine A1 receptor-like immunoreactivity in the CA2/CA3a region of the adult rat hippocampus. Neuroscience. 93, 955-967 (1999).
78. Simons S. B, Caruana D. A, Zhao M, & Dudek S. M. Caffeine-induced synaptic potentiation in hippocampal CA2 neurons. Nat. Neurosci. 15, 23-25 (2012).
79. Mons N, Segu L, Nogues X, & Buhot M. C. Effects of age and spatial learning on adenylyl cyclase mRNA expression in the mouse hippocampus. Neurobiol. Aging. 25, 1095-1106 (2004).
80. Visel A, Alvarez-Bolado G, Thaller C, & Eichele G. Comprehensive analysis of the expression patterns of the adenylate cyclase gene family in the developing and adult mouse brain. J. Comp. Neurol. 496, 684-697 (2006).
81. Watson C, & Paxinos G. Chemoarchitecton Atlas Mouse Brain (Academic Press, 2009).
82. Evans P. R, Lee S. E, Smith Y, & Hepler J. R. Postnatal developmental expression of regulator of G protein signaling 14 (RGS14) in the mouse brain. J. Comp. Neurol. 522, 186-203 (2013).
83. Lee Y. S, & Silva A. J. The molecular and cellular biology of enhanced cognition. Nat. Rev. Neurosci. 10, 126-140 (2009).
84. Wintzer M. E, Boehringer R, Polygalov D, & McHugh T. J. The hippocampal CA2 ensemble is sensitive to contextual change. J. Neurosci. 34, 3056-3066 (2014).
85. Mankin E. A, Diehl G. W, Sparks F. T, Leutgeb S, & Leutgeb J. K. Hippocampal CA2 activity patterns change over time to a larger extent than between spatial contexts. Neuron. 85, 190-201 (2015).
86. Martig A. K, & Mizumori S. J. Y. Ventral tegmental area disruption selectively affects CA1/CA2 but not CA3 place fields during a differential reward working memory task. Hippocampus. 21, 172-184 (2011).
87. Lee H, Wang C, Deshmukh S. S, & Knierim J. J. Neural population evidence of functional heterogeneity along the CA3 transverse axis: pattern completion versus pattern separation. Neuron. 87, 1093-1105 (2015).
88. Lu L, Igarashi K. M, Witter M. P, Moser E. I, & Moser M. B. Topography of place maps along the CA3 to CA2 axis of the hippocampus. Neuron. 87, 1078-1092 (2015).
89. von Heimendahl M, Rao R. P, & Brecht M. Weak and nondiscriminative responses to conspecifics in the rat hippocampus. J. Neurosci. 32, 2129-2141 (2012).
90. Lee H. J, Macbeth A. H, Pagani J. H, & Young W. S. Oxytocin: the great facilitator of life. Prog. Neurobiol. 88, 127-151 (2009).
91. Wersinger S. R, Ginns E. I, O'Carroll A. M, Lolait S. J, & Young W. S. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol. Psychiatry. 7, 975-984 (2002).
92. Wersinger S. R, Temple J. L, Caldwell H. K, & Young W. S. Inactivation of the oxytocin and the vasopressin (Avp) 1b receptor genes, but not the Avp 1a receptor gene, differentially impairs the Bruce effect in laboratory mice (Mus musculus). Endocrinology. 149, 116-121 (2008).
93. DeVito L. M, et al. Vasopressin 1b receptor knock-out impairs memory for temporal order. J. Neurosci. 29, 2676-2683 (2009).
94. Stevenson E. L, & Caldwell H. K. Lesions to the CA2 region of the hippocampus impair social memory in mice. Eur. J. Neurosci. 40, 3294-3301 (2014).
95. Tymianski M. Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat. Neurosci. 14, 1369-1373 (2011).
96. Hatanpaa K. J, et al. Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields. J. Neuropathol. Exp. Neurol. 73, 136-142 (2014).
97. Sommer W. Erkrankung des ammonshorns als aetiologisches moment der epilepsie. Arch. Psychiat. Nervenkr. 10, 631-675 (in German) (1880).
98. Corsellis J. A, & Bruton C. J. Neuropathology of status epilepticus in humans. Adv. Neurol. 34, 129-139 (1983).
99. Bratz E. Ammonshornbefunde bei epileptikern. Arch. Psychiat. Nervenkr. 31, 820-836 (in German) (1899).
100. Steve T. A, Jirsch J. D, & Gross D. W. Quantification of subfield pathology in hippocampal sclerosis: a systematic review and meta-Analysis. Epilepsy Res. 108, 1279-1285 (2014).
101. Maxwell W. L, et al. There is differential loss of pyramidal cells from the human hippocampus with survival after blunt head injury. J. Neuropathol. Exp. Neurol. 62, 272-279 (2003).
102. Sloviter R. S, Sollas A. L, Barbaro N. M, & Laxer K. D. Calcium-binding protein (calbindin D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. Comp. Neurol. 308, 381-396 (1991).
103. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239, 57-69 (1982).
104. Kotapka M. J, Graham D. I, Adams J. H, & Gennarelli T. A. Hippocampal pathology in fatal non-missile human head injury. Acta Neuropathol. 83, 530-534 (1992).
105. Cavazos J. E, Das I, & Sutula T. P. Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J. Neurosci. 14, 3106-3121 (1994).
106. Miyamoto O, et al. Neurotoxicity of Clostridium perfringens epsilon-Toxin for the rat hippocampus via the glutamatergic system. Infect. Immun. 66, 2501-2508 (1998).
107. Sadowski M, et al. Pattern of neuronal loss in the rat hippocampus following experimental cardiac arrest-induced ischemia. J. Neurol. Sci. 168, 13-20 (1999).
108. Yang G, et al. Regional difference of neuronal vulnerability in the murine hippocampus after transient forebrain ischemia. Brain Res. 870, 195-198 (2000).
109. Bothe H. W, Bosma H. J, Hofer H, Hossmann K. A, & Angermeier W. F. Selective vulnerability of hippocampus and disturbances of memory storage after mild unilateral ischemia of gerbil brain. Stroke. 17, 1160-1163 (1986).
110. Buckmaster P. S, Wen X, Toyoda I, Gulland F. M. D, & Van Bonn W. Hippocampal neuropathology of domoic acid-induced epilepsy in California sea lions (Zalophus californianus). J. Comp. Neurol. 522, 1691-1706 (2014).
111. Young D, & Dragunow M. Neuronal injury following electrically induced status epilepticus with and without adenosine receptor antagonism. Exp. Neurol. 133, 125-137 (1995).
112. Xu B, Michalski B, Racine R. J, & Fahnestock M. Continuous infusion of neurotrophin 3 triggers sprouting, decreases the levels of TrkA and TrkC, and inhibits epileptogenesis and activity-dependent axonal growth in adult rats. Neuroscience. 115, 1295-1308 (2002).
113. Gluckman P, et al A role for IGF 1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182, 593-599 (1992).
114. Miltiadous P, Stamatakis A, & Stylianopoulou F. Neuroprotective effects of IGF I following kainic acid induced hippocampal degeneration in the rat. Cell. Mol. Neurobiol. 30, 347-360 (2009).
115. Sun X, et al. Insulin/PI3K signaling protects dentate neurons from oxygen-glucose deprivation in organotypic slice cultures. J. Neurochem. 112, 377-388 (2010).
116. Chung Y. H, et al. Region-specific alterations in insulin-like growth factor I receptor in the central nervous system of nNOS knockout mice. Brain Res. 1021, 132-139 (2004).
117. Beilharz E. J, et al. Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res. Mol. Brain Res. 18, 209-215 (1993).
118. Kang T. C, et al. The somatostatin receptors in the normal and epileptic hippocampus of the gerbil: subtype-specific localization and its alteration. Brain Res. 986, 91-102 (2003).
119. Arida R. M, Scorza F. A, de Amorim Carvalho R, & Cavalheiro E. A. Proechimys guyannensis: an animal model of resistance to epilepsy. Epilepsia 46 (Suppl. 5), 189-197 (2005).
120. Scorza C. A, et al. Distinctive hippocampal CA2 subfield of the Amazon rodent Proechimys. Neuroscience. 169, 965-973 (2010).
121. Han C, Kasai N, & Torimitsu K. CA2: the most vulnerable sector to bicuculline exposure in rat hippocampal slice cultures. Neuroreport. 16, 333-336 (2005).
122. Mattson M. P, & Kater S. B. Development and selective neurodegeneration in cell cultures from different hippocampal regions. Brain Res. 490, 110-125 (1989).
123. Wittner L, et al. The epileptic human hippocampal cornu ammonis 2 region generates spontaneous interictal-like activity in vitro. Brain. 132, 3032-3046 (2009).
124. Cohen I, Navarro V, Clemenceau S, Baulac M, & Miles R. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science. 298, 1418-1421 (2002).
125. Williamson A, & Spencer D. D. Electrophysiological characterization of CA2 pyramidal cells from epileptic humans. Hippocampus. 4, 226-237 (1994).
126. Wong R. K, & Traub R. D. Synchronized burst discharge in disinhibited hippocampal slice. I. Initiation in CA2 CA3 region. J. Neurophysiol. 49, 442-458 (1983).
127. Häussler U, Rinas K, Kilias A, Egert U, & Haas C. A. Mossy fiber sprouting and pyramidal cell dispersion in the hippocampal CA2 region in a mouse model of temporal lobe epilepsy. Hippocampus http://.dx.doi.org/10.1002/hipo.22543 (2015).
128. Lavenex P, Lavenex P. B, Bennett J. L, & Amaral D. G. Postmortem changes in the neuroanatomical characteristics of the primate brain: hippocampal formation. J. Comp. Neurol. 512, 27-51 (2009).
129. Bauman M. L, & Kemper T. L. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23, 183-187 (2005).
130. Boucher J, Mayes A, & Bigham S. Memory in autistic spectrum disorder. Psychol. Bull. 138, 458-496 (2012).
131. Deykin E. Y, & MacMahon B. The incidence of seizures among children with autistic symptoms. Am. J. Psychiatry. 136, 1310-1312 (1979).
132. Shen E. H, Overly C. C, & Jones A. R. The Allen Human Brain Atlas: comprehensive gene expression mapping of the human brain. Trends Neurosci. 35, 711-714 (2012).
133. Benes F. M, Kwok E. W, Vincent S. L, & Todtenkopf M. S A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry. 44, 88-97 (1998).
134. Zhang Z. J, & Reynolds G. P A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 55, 1-10 (2002).
135. Benes F. M, et al. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl Acad. Sci. USA. 104, 10164-10169 (2007).
136. Benes F. M, Todtenkopf M. S, & Kostoulakos P. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus. 11, 482-491 (2001).
137. Gao X. M, et al. Ionotropic glutamate receptors and expression of N methyl-d aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry. 157, 1141-1149 (2000).
138. Jin C. Y, Anichtchik O, & Panula P. Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases. Br. J. Pharmacol. 157, 118-129 (2009).
139. Schobel S. A, et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron. 78, 81-93 (2013).
140. Fatemi S. H, Earle J. A, & McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry. 5, 654-663 (2000).
141. Berretta S, Gisabella B, & Benes F. M A rodent model of schizophrenia derived from postmortem studies. Behav. Brain Res. 204, 363-368 (2009).
142. Pikkarainen M, Rönkkö S, Savander V, Insausti R, & Pitkänen A. Projections from the lateral, basal, and accessory basal nuclei of the amygdala to the hippocampal formation in rat. J. Comp. Neurol. 403, 229-260 (1999).
143. Ding S. L, Haber S. N, & Van Hoesen G. W. Stratum radiatum of CA2 is an additional target of the perforant path in humans and monkeys. Neuroreport. 21, 245-249 (2010).
144. Leranth C, & Ribak C. E. Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: a possible key to this region's resistance to epileptic damage. Exp. Brain Res. 85, 129-136 (1991).
145. Seress L, Nitsch R, & Leranth C. Calretinin immunoreactivity in the monkey hippocampal formation -I. Light and electron microscopic characteristics and co localization with other calcium-binding proteins. Neuroscience. 55, 775-796 (1993).
146. Utal A. K, Stopka A. L, Roy M, & Coleman P. D. PEP 19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease. Neuroscience. 86, 1055-1063 (1998).
147. Zimmermann B, Girard F, Mészàr Z, & Celio M. R. Expression of the calcium binding proteins Necab 1,-2 and -3 in the adult mouse hippocampus and dentate gyrus. Brain Res. 1528, 1-7 (2013).
148. Palmiter R. D, Cole T. B, Quaife C. J, & Findley S. D. ZnT 3, a putative transporter of zinc into synaptic vesicles. Proc. Natl Acad. Sci. USA. 93, 14934-14939 (1996).
149. Yamamoto M, Marshall P, Hemmendinger L. M, Boyer A. B, & Caviness V. S. Distribution of glucuronic acid-And-sulfate-containing glycoproteins in the central nervous system of the adult mouse. Neurosci. Res. 5, 273-298 (1988).
150. Costa C, et al. Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse. J. Chem. Neuroanat. 33, 111-123 (2007).
151. McRae P. A, Baranov E, Sarode S, Brooks Kayal A. R, & Porter B. E. Aggrecan expression, a component of the inhibitory interneuron perineuronal net, is altered following an early-life seizure. Neurobiol. Dis. 39, 439-448 (2010).
152. Fuxe K, et al. On the regional distribution of heparan sulfate proteoglycan immunoreactivity in the rat brain. Brain Res. 636, 131-138 (1994).
153. Brückner G, Grosche J, Hartlage-Rübsamen M, Schmidt S, & Schachner M. Region and lamina-specific distribution of extracellular matrix proteoglycans, hyaluronan and tenascin R in the mouse hippocampal formation. J. Chem. Neuroanat. 26, 37-50 (2003).
154. Fuxe K, Tinner B, Staines W, David G, & Agnati L. F. Regional distribution of neural cell adhesion molecule immunoreactivity in the adult rat telencephalon and diencephalon. Partial colocalization with heparan sulfate proteoglycan immunoreactivity. Brain Res. 746, 25-33 (1997).
155. Laeremans A, et al. AMIGO2 mRNA expression in hippocampal CA2 and CA3a. Brain Struct. Funct. 218, 123-130 (2012).
156. Barlow G. M, Micales B, Lyons G. E, & Korenberg J. R. Down syndrome cell adhesion molecule is conserved in mouse and highly expressed in the adult mouse brain. Cytogenet. Cell Genet. 94, 155-162 (2001).
157. Shen L, et al. Altered expression of Dscam in temporal lobe tissue from human and experimental animals. Synapse. 65, 975-982 (2011).
158. Eroglu C. The role of astrocyte-secreted matricellular proteins in central nervous system development and function. J. Cell Commun. Signal. 3, 167-176 (2009).
159. Hawrylycz M. J, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 489, 391-399 (2012).
160. Woodward W. R, et al. Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. J. Neurosci. 12, 142-152 (1992).
161. Eckenstein F. P, Andersson C, Kuzis K, & Woodward W. R. Distribution of acidic and basic fibroblast growth factors in the mature, injured and developing rat nervous system. Prog. Brain Res. 103, 55-64 (1994).
162. Williams T. E, et al. Characterization and distribution of basic fibroblast growth factor-containing cells in the rat hippocampus. J. Comp. Neurol. 370, 147-158 (1996).
163. Gómez-Pinilla F, van der Wal E. A, & Cotman C. W. Possible coordinated gene expressions for FGF receptor, FGF 5, and FGF 2 following seizures. Exp. Neurol. 133, 164-174 (1995).
164. Gonzalez A. M, Berry M, Maher P. A, Logan A, & Baird A A comprehensive analysis of the distribution of FGF 2 and FGFR1 in the rat brain. Brain Res. 701, 201-226 (1995).
165. Ernfors P, Ibáñez C. F, Ebendal T, Olson L, & Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc. Natl Acad. Sci. USA. 87, 5454-5458 (1990).
166. Vigers A. J, Baquet Z. C, & Jones K. R. Expression of neurotrophin 3 in the mouse forebrain: insights from a targeted LacZ reporter. J. Comp. Neurol. 416, 398-415 (2000).
167. Friedman W. J, Ernfors P, & Persson H. Transient and persistent expression of NT 3/HDNF mRNA in the rat brain during postnatal development. J. Neurosci. 11, 1577-1584 (1991).
168. Tucker M. S, et al. Localization of immunoreactive epidermal growth factor receptor in neonatal and adult rat hippocampus. Brain Res. 631, 65-71 (1993).
169. Bondy C, Werner H, Roberts C. T, & LeRoith D. Cellular pattern of type I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience. 46, 909-923 (1992).
170. Stenvers K. L, Zimmermann E. M, Gallagher M, & Lund P. K. Expression of insulin-like growth factor binding protein 4 and -5 mRNAs in adult rat forebrain. J. Comp. Neurol. 339, 91-105 (1994).
171. Stephan A. H, et al A dramatic increase of C1q protein in the CNS during normal aging. J. Neurosci. 33, 13460-13474 (2013).
172. Lopez M. E, Klein A. D, & Scott M. P. Complement is dispensable for neurodegeneration in Niemann-Pick disease type C. J. Neuroinflammation. 9, 216 (2012).
173. Kwak S. E, et al. The expression of somatostatin receptors in the hippocampus of pilocarpine-induced rat epilepsy model. Neuropeptides. 42, 569-583 (2008).
174. Berger T, & Frotscher M. Distribution and morphological characteristics of oligodendrocytes in the rat hippocampus in situ and in vitro: an immunocytochemical study with the monoclonal Rip antibody. J. Neurocytol. 23, 61-74 (1994).
175. Smith A. S, Williams Avram S. K, Cymerblit-Sabba A, Song J, & Young W. S. Targeted activation of the hippocampal CA2 area strongly enhances social memory. Mol. Psychiatry http://.dx.doi.org/10.1038/mp.2015.189 (2016).
176. Piskorowski R. A, et al. Age-dependent specific changes in area CA2 of the hippocampus and social memory deficit in a mouse model of the 22q11.2 deletion syndrome. Neuron. 89, 163-176 (2016).